Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Orchard Therapeutics plc (ORTX)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | | |
|
Returns on Capital |
ROIC (excluding intangibles) | -109.3% | -73.6% | -62.0% | -105.1% | -180861.5% | | |
ROIC (including intangibles) | -171.5% | -65.1% | -85.9% | -52.4% | 25800.6% | -3279.8% | |
ROE | -179.3% | -70.5% | -87.6% | -57.0% | -75.8% | -44.6% | |
ROA | -80.5% | -45.9% | -55.6% | -42.7% | -64.5% | -39.6% | |
|
Cash Conversion Cycle |
Days sales outstanding | 136.4 | 322.5 | 123.5 | 209.4 | 369.7 | | |
Days payables outstanding | 502.3 | 16,163.4 | 3,757.8 | 5,433.7 | 15,676.8 | | |
Cash conversion cycle | -365.9 | -15,840.9 | -3,634.3 | -5,224.3 | -15,307.1 | | |
|